The global Bioprocess Validation Market, valued at USD 479.30 million in 2024, is poised for significant growth and is projected to reach USD 1,132.06 million by 2034, expanding at a CAGR of 9.0% from 2025 to 2034. The market’s upward trajectory is fueled by the rapid expansion of biopharmaceutical manufacturing, stringent regulatory standards imposed by health authorities, and...